H W Reesink
Overview
Explore the profile of H W Reesink including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
251
Citations
1954
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stelma F, van der Ree M, Jansen L, Peters M, Janssen H, Zaaijer H, et al.
J Viral Hepat
. 2017 Jun;
24(12):1107-1113.
PMID: 28632898
Combining peginterferon-alfa-2a (pegIFN) with a nucleotide analogue can result in higher rates of HBsAg loss than either therapy given alone. Here, we investigated the durability of the response to combination...
2.
Willemse S, Baak L, Kuiken S, van der Sluys Veer A, Lettinga K, van der Meer J, et al.
J Viral Hepat
. 2016 Jul;
23(12):950-954.
PMID: 27405785
Chronic hepatitis C virus (HCV) infection is a major cause of chronic liver disease and liver-related death. Recently, multiple regimens of different direct-acting antiviral agents (DAAs) have been registered. Although...
3.
Santagostino E, Pol S, Olveira A, Reesink H, van Erpecum K, Bogomolov P, et al.
Haemophilia
. 2016 Jun;
22(5):692-9.
PMID: 27339614
Aim: This study explores the potential role of a novel interferon-containing regimen for treatment of patients with chronic hepatitis C (CHC) and underlying haemophilia. Methods: This trial (NCT01741545) was an...
4.
Mauser-Bunschoten E, Bresters D, Reesink H, Roosendaal G, Chamuleau R, Haan E, et al.
Haemophilia
. 2016 May;
1(1):45-53.
PMID: 27214221
To evaluate the effect and side-effects of alpha interferon 2B (IFN) treatment in haemophilia patients with chronic hepatitis C (positive HCV antibody test, positive HCV-RNA test and ALT levels >2.5...
5.
Willemse S, Jansen L, de Niet A, Sinnige M, Takkenberg R, Verheij J, et al.
Antiviral Res
. 2016 May;
131:148-55.
PMID: 27155352
Introduction: Interferon-y-inducible protein-10 (IP-10), also called CXCL10, is produced by different types of cells such as monocytes, neutrophils and hepatocytes. IP-10 functions as an inflammatory cytokine, which after binding to...
6.
Stelma F, Jansen L, Sinnige M, van Dort K, Takkenberg R, Janssen H, et al.
J Viral Hepat
. 2016 Mar;
23(8):652-9.
PMID: 26945896
Current treatment for chronic hepatitis B infection (CHB) consists of interferon-based therapy. However, for unknown reasons, a large proportion of patients with CHB do not respond to this treatment. Hence,...
7.
Vanhommerig J, Lambers F, Schinkel J, Geskus R, Arends J, van de Laar T, et al.
Open Forum Infect Dis
. 2015 Dec;
2(3):ofv115.
PMID: 26634219
Background. Since 2000, incidence of sexually acquired hepatitis C virus (HCV)-infection has increased among human immunodeficiency virus (HIV)-infected men who have sex with men (MSM). To date, few case-control and...
8.
Willemse S, Razavi-Shearer D, Zuure F, Veldhuijzen I, Croes E, van der Meer A, et al.
Neth J Med
. 2015 Nov;
73(9):417-31.
PMID: 26582807
Background & Aims: Prevalence of hepatitis C virus (HCV) infection in the Netherlands is low (anti-HCV prevalence 0.22%). All-oral treatment with direct-acting antivirals (DAAs) is tolerable and effective but expensive....
9.
van der Ree M, van der Meer A, van Nuenen A, de Bruijne J, Ottosen S, Janssen H, et al.
Aliment Pharmacol Ther
. 2015 Oct;
43(1):102-13.
PMID: 26503793
Background: MicroRNA-122 (miR-122) is an important host factor for hepatitis C virus replication. Administration of miravirsen, an anti-miR-122 oligonucleotide, resulted in a dose dependent and prolonged decrease in HCV RNA...
10.
Gane E, Kershenobich D, Seguin-Devaux C, Kristian P, Aho I, Dalgard O, et al.
J Viral Hepat
. 2015 Jan;
22 Suppl 1:46-73.
PMID: 25560841
The hepatitis C virus (HCV) epidemic was forecasted through 2030 for 15 countries, and the relative impact of two scenarios was considered: (i) increased treatment efficacy while holding the treated...